Dendritic Cells and Chemokine-Directed Migration in Transplantation: Where Are We Headed?

Clinics in Laboratory Medicine

Volumn 28, Issue 3, 2008, Pages 375-384

  Colvin, Bridget L ^a,b   Matta, Benjamin M ^a,b   Thomson, Angus W ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR7; CYCLOSPORIN; DEXAMETHASONE; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; RAPAMYCIN; SECONDARY LYMPHOID TISSUE CHEMOKINE; TACROLIMUS;

ALLOGRAFT; ALLOIMMUNITY; ANTIGEN PRESENTING CELL; B LYMPHOCYTE; CELL FUNCTION; CELL MIGRATION; DENDRITIC CELL; DRUG MECHANISM; GRAFT RECIPIENT; HISTOCOMPATIBILITY; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; ORGAN DONOR; ORGAN TRANSPLANTATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; T LYMPHOCYTE;

ANIMALS; BIOLOGICAL TRANSPORT; CELL MOVEMENT; CHEMOKINES; DENDRITIC CELLS; GRAFT REJECTION; HUMANS; MICE; RECEPTORS, CHEMOKINE; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION TOLERANCE;

EID: 56349130879     PISSN: 02722712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cll.2008.07.003     Document Type: Review

References (55)

1. Lukacs-Kornek V., Engel D., Tacke F., et al. The role of chemokines and their receptors in dendritic cell biology. Front Biosci 13 (2008) 2238-2252
2. Sozzani S., Allavena P., Vecchi A., et al. The role of chemokines in the regulation of dendritic cell trafficking. J Leukoc Biol 66 (1999) 1-9
3. Vecchi A., Massimiliano L., Ramponi S., et al. Differential responsiveness to constitutive vs. inducible chemokines of immature and mature mouse dendritic cells. J Leukoc Biol 66 (1999) 489-494
4. Colvin B.L., and Thomson A.W. Location, location, location: dendritic cell trafficking and transplant tolerance. Curr Opin Organ Transplant 12 (2007) 1-4
5. Colvin B.L., and Thomson A.W. Chemokines, their receptors, and transplant outcome. Transplantation 74 (2002) 149-155
6. Abe M., Zahorchak A.F., Colvin B.L., et al. Migratory responses of murine hepatic myeloid, lymphoid-related, and plasmacytoid dendritic cells to CC chemokines. Transplantation 78 (2004) 762-765
7. Lau A.H., Thomson A.W., Colvin B.L., et al. Chronic ethanol exposure affects in vivo migration of hepatic dendritic cells to secondary lymphoid tissue. Hum Immunol 68 (2007) 577-585
8. Moldenhauer A., Moore M.A., Schmidt K., et al. Differences in the transmigration of different dendritic cells. Exp Hematol 34 (2006) 745-752
9. Muller W.A., and Randolph G.J. Migration of leukocytes across endothelium and beyond: molecules involved in the transmigration and fate of monocytes. J Leukoc Biol 66 (1999) 698-704
10. Randolph G.J., Sanchez-Schmitz G., et al. The CD16(+) (FcgammaRIII(+)) subset of human monocytes preferentially becomes migratory dendritic cells in a model tissue setting. J Exp Med 196 (2002) 517-527
11. Leon B., Martinez del Hoyo G., Parrillas V., et al. Dendritic cell differentiation potential of mouse monocytes: monocytes represent immediate precursors of CD8- and CD8+ splenic dendritic cells. Blood 103 (2004) 2668-2676
12. Ochando J.C., Homma C., et al. Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts. Nat Immunol 7 (2006) 652-662
13. Ueta H., Shi C., Miyanari N., et al. Systemic transmigration of allosensitizing donor dendritic cells to host secondary lymphoid organs after rat liver transplantation. Hepatology 47 (2008) 1352-1362
14. Allan R.S., Waithman J., et al. Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming. Immunity 25 (2006) 153-162
15. Colvin B.L., Morelli A.E., et al. Comparative evaluation of CC chemokine-induced migration of murine CD8alpha+ and CD8alpha- dendritic cells and their in vivo trafficking. J Leukoc Biol 75 (2004) 275-285
16. Jang M.H., Sougawa N., et al. CCR7 is critically important for migration of dendritic cells in intestinal lamina propria to mesenteric lymph nodes. J Immunol 176 (2006) 803-810
17. Lan Y.Y., De Creus A., et al. The sphingosine-1-phosphate receptor agonist FTY720 modulates dendritic cell trafficking in vivo. Am J Transplant 5 (2005) 2649-2659
18. Ohl L., Mohaupt M., Czeloth N., et al. CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. Immunity 21 (2004) 279-288
19. Sordi V., Bianchi G., Buracchi C., et al. Differential effects of immunosuppressive drugs on chemokine receptor CCR7 in human monocyte-derived dendritic cells: selective upregulation by rapamycin. Transplantation 82 (2006) 826-834
20. Taner T., Hackstein H., Wang Z., et al. Rapamycin-treated, alloantigen-pulsed host dendritic cells induce ag-specific T cell regulation and prolong graft survival. Am J Transplant 5 (2005) 228-236
21. Sille F.C., Visser A., et al. T cell priming by tissue-derived dendritic cells: new insights from recent murine studies. Cell Immunol 237 (2005) 77-85
22. Worbs T., and Forster R. A key role for CCR7 in establishing central and peripheral tolerance. Trends Immunol 28 (2007) 274-280
23. Colvin B.L., Wang Z., et al. CXCL9 antagonism further extends prolonged cardiac allograft survival in CCL19/CCL21-deficient mice. Am J Transplant 5 (2005) 2104-2113
24. Wang L., Han R., Lee I., et al. Permanent survival of fully MHC-mismatched islet allografts by targeting a single chemokine receptor pathway. J Immunol 175 (2005) 6311-6318
25. Nakano H., and Gunn M.D. Gene duplications at the chemokine locus on mouse chromosome 4: multiple strain-specific haplotypes and the deletion of secondary lymphoid-organ chemokine and EBI-1 ligand chemokine genes in the plt mutation. J Immunol 166 (2001) 361-369
26. Mori S., Nakano H., Aritomi K., et al. Mice lacking expression of the chemokines CCL21-ser and CCL19 (plt mice) demonstrate delayed but enhanced T cell immune responses. J Exp Med 193 (2001) 207-218
27. Beckmann J.H., Yan S., et al. Prolongation of allograft survival in ccr7-deficient mice. Transplantation 77 (2004) 1809-1814
28. Ziegler E., Gueler F., Rong S., et al. CCL19-IgG prevents allograft rejection by impairment of immune cell trafficking. J Am Soc Nephrol 17 (2006) 2521-2532
29. Fiorina P., Jurewicz M., Vergani A., et al. Phenotypic and functional differences between wild-type and CCR2-/- dendritic cells: implications for islet transplantation. Transplantation 85 (2008) 1030-1038
30. Lakkis F.G., Arakelov A., et al. Immunologic "ignorance" of vascularized organ transplants in the absence of secondary lymphoid tissue. Nat Med 6 (2000) 686-688
31. Jin Y., Shen L., Chong E.M., et al. The chemokine receptor CCR7 mediates corneal antigen-presenting cell trafficking. Mol Vis 13 (2007) 626-634
32. Larsen C.P., Steinman R.M., et al. Migration and maturation of Langerhans cells in skin transplants and explants. J Exp Med 172 (1990) 1483-1493
33. Larsen C.P., Morris P.J., et al. Migration of dendritic leukocytes from cardiac allografts into host spleens. A novel pathway for initiation of rejection. J Exp Med 171 (1990) 307-314
34. Isaacs J.D. T cell immunomodulation-the Holy Grail of therapeutic tolerance. Curr Opin Pharmacol 7 (2007) 418-425
35. Knechtle S.J. Treatment with immunotoxin. Philos Trans R Soc Lond B Biol Sci 356 (2001) 681-689
36. Probst H.C., Tschannen K., et al. Histological analysis of CD11c-DTR/GFP mice after in vivo depletion of dendritic cells. Clin Exp Immunol 141 (2005) 398-404
37. Blasius A.L., Barchet W., et al. Development and function of murine B220+CD11c+NK1.1+ cells identify them as a subset of NK cells. J Exp Med 204 (2007) 2561-2568
38. Collin M.P., Munster D., et al. In vitro depletion of tissue-derived dendritic cells by CMRF-44 antibody and alemtuzumab: implications for the control of graft-versus-host disease. Transplantation 79 (2005) 722-725
39. Auchincloss Jr. H., Lee R., Shea S., et al. The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice. Proc Natl Acad Sci U S A 90 (1993) 3373-3377
40. Chitilian H.V., and Auchincloss Jr. H. Studies of transplantation immunology with major histocompatibility complex knockout mice. J Heart Lung Transplant 16 (1997) 153-159
41. Grusby M.J., Auchincloss Jr. H., et al. Mice lacking major histocompatibility complex class I and class II molecules. Proc Natl Acad Sci U S A 90 (1993) 3913-3917
42. Ochando J.C., Krieger N.R., et al. Direct versus indirect allorecognition: visualization of dendritic cell distribution and interactions during rejection and tolerization. Am J Transplant 6 (2006) 2488-2496
43. Worbs T., Bode U., Yan S., et al. Oral tolerance originates in the intestinal immune system and relies on antigen carriage by dendritic cells. J Exp Med 203 (2006) 519-527
44. Furuhashi T., Yamaguchi Y., Wang F.S., et al. Hepatic CCR7lowCD62LlowCD45RClow allograft dendritic cells migrate to the splenic red pulp in immunologically unresponsive rats. J Surg Res 124 (2005) 29-37
45. Duncan M.D., and Wilkes D.S. Transplant-related immunosuppression: a review of immunosuppression and pulmonary infections. Proc Am Thorac Soc 2 (2005) 449-455
46. Miao C.H. Recent advances in immune modulation. Curr Gene Ther 7 (2007) 391-402
47. Abe M., and Thomson A.W. Influence of immunosuppressive drugs on dendritic cells. Transpl Immunol 11 (2003) 357-365
48. Coates P.T., Colvin B.L., et al. Pharmacologic, biologic, and genetic engineering approaches to potentiation of donor-derived dendritic cell tolerogenicity. Transplantation 75 (2003) 32S-36S
49. Hackstein H., and Thomson A.W. Dendritic cells: emerging pharmacological targets of immunosuppressive drugs. Nat Rev Immunol 4 (2004) 24-34
50. Paterson A.M., Yates S.F., et al. The new immunosuppression: intervention at the dendritic cell-T-cell interface. Curr Drug Targets Immune Endocr Metabol Disord 5 (2005) 397-411
51. Liu Q., Chen T., Chen G., et al. Triptolide impairs dendritic cell migration by inhibiting CCR7 and COX-2 expression through PI3-K/Akt and NF-kappaB pathways. Mol Immunol 44 (2007) 2686-2696
52. Lagaraine C., Hoarau C., Chabot V., et al. Mycophenolic acid-treated human dendritic cells have a mature migratory phenotype and inhibit allogeneic responses via direct and indirect pathways. Int Immunol 17 (2005) 351-363
53. Takayama T., Morelli A.E., Onai N., et al. Mammalian and viral IL-10 enhance C-C chemokine receptor 5 but down-regulate C-C chemokine receptor 7 expression by myeloid dendritic cells: impact on chemotactic responses and in vivo homing ability. J Immunol 166 (2001) 7136-7143
54. Garrod K.R., Chang C.K., et al. Targeted lymphoid homing of dendritic cells is required for prolongation of allograft survival. J Immunol 177 (2006) 863-868
55. Schlichting C.L., Schareck W.D., et al. Involvement of dendritic cells in allograft rejection new implications of dendritic cell-endothelial cell interactions. Mini Rev Med Chem 7 (2007) 423-428